IGC IGC Pharma Inc: Bathi resik saben saham (EPS TTM)

The implementation of AI-driven automatic capsule filling systems is stimulating growth for IGC Pharma, Inc. (IGC), as evidenced by the current annual net income per share, where the parameter value equals -0.08. This success is based on strict ESG control of raw materials and eco-friendly production standards. Additional resilience is provided by a patent monopoly in the Alzheimer's drug niche, which allows the company to maintain pricing power over its products.
Rincian analitis perusahaan IGC Pharma, Inc. (IGC)

This indicator is calculated as the ratio of total net income to the total number of shares outstanding. The metric eliminates the impact of issuance volume, revealing the actual efficiency of the financial model regardless of one-off market spikes. For IGC Pharma, Inc. (IGC), such an assessment is critical, as the inelastic demand for a unique Alzheimer's therapy should convert into stable profit growth. Analyzing the annual earnings per share TTM allows for the removal of temporary distortions. The curve's dynamics confirm the long-term sustainability of the business.